Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth - PubMed (original) (raw)
. 2003 Jul;285(1):G20-30.
doi: 10.1152/ajpgi.00474.2002. Epub 2003 Mar 26.
Affiliations
- PMID: 12660143
- DOI: 10.1152/ajpgi.00474.2002
Free article
Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth
Jianye Xu et al. Am J Physiol Gastrointest Liver Physiol. 2003 Jul.
Free article
Abstract
Hepatic fibrogenesis occurs as a wound-healing process after many forms of chronic liver injury. Hepatic fibrosis ultimately leads to cirrhosis if not treated effectively. During liver injury, quiescent hepatic stellate cells (HSC), the most relevant cell type, become active and proliferative. Oxidative stress is a major and critical factor for HSC activation. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) inhibits the proliferation of nonadipocytes. The level of PPAR-gamma is dramatically diminished along with activation of HSC. Curcumin, the yellow pigment in curry, is a potent antioxidant. The aims of this study were to evaluate the effect of curcumin on HSC proliferation and to begin elucidating underlying mechanisms. It was hypothesized that curcumin might inhibit the proliferation of activated HSC by inducing PPAR-gamma gene expression and reviving PPAR-gamma activation. Our results indicated that curcumin significantly inhibited the proliferation of activated HSC and induced apoptosis in vitro. We demonstrated, for the first time, that curcumin dramatically induced the gene expression of PPAR-gamma and activated PPAR-gamma in activated HSC. Blocking its trans-activating activity by a PPAR-gamma antagonist markedly abrogated the effects of curcumin on inhibition of cell proliferation. Our results provide a novel insight into mechanisms underlying the inhibition of activated HSC growth by curcumin. The characteristics of curcumin, including antioxidant potential, reduction of activated HSC growth, and no adverse health effects, make it a potential antifibrotic candidate for prevention and treatment of hepatic fibrosis.
Similar articles
- Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
Zheng S, Chen A. Zheng S, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G113-23. doi: 10.1152/ajpgi.00200.2006. Epub 2006 Sep 7. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 16959952 - The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.
Chen A, Zhang L, Xu J, Tang J. Chen A, et al. Biochem J. 2002 Dec 15;368(Pt 3):695-704. doi: 10.1042/BJ20020894. Biochem J. 2002. PMID: 12223099 Free PMC article. - Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Fu Y, et al. Mol Pharmacol. 2008 Feb;73(2):399-409. doi: 10.1124/mol.107.039818. Epub 2007 Nov 15. Mol Pharmacol. 2008. PMID: 18006644 - [The expression of PPAR gamma in gastric cancer].
Morita D, Ichikura T, Mochizuki H. Morita D, et al. Nihon Rinsho. 2001 Apr;59 Suppl 4:595-7. Nihon Rinsho. 2001. PMID: 11424448 Review. Japanese. No abstract available. - Role of transcriptional factors in stellate cell activation.
Rippe RA. Rippe RA. Alcohol Clin Exp Res. 1999 May;23(5):926-9. Alcohol Clin Exp Res. 1999. PMID: 10371416 Review.
Cited by
- Curcumin targets multiple pathways to halt hepatic stellate cell activation: updated mechanisms in vitro and in vivo.
Tang Y. Tang Y. Dig Dis Sci. 2015 Jun;60(6):1554-64. doi: 10.1007/s10620-014-3487-6. Epub 2014 Dec 23. Dig Dis Sci. 2015. PMID: 25532502 Review. - Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling.
Chen A, Zheng S. Chen A, et al. Br J Pharmacol. 2008 Feb;153(3):557-67. doi: 10.1038/sj.bjp.0707542. Epub 2007 Oct 29. Br J Pharmacol. 2008. PMID: 17965732 Free PMC article. - Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.
Di Paola R, Cuzzocrea S. Di Paola R, et al. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):157-75. doi: 10.1007/s00210-007-0141-2. Epub 2007 Mar 13. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17394034 Review. - Curcumin: potential for hepatic fibrosis therapy?
O'Connell MA, Rushworth SA. O'Connell MA, et al. Br J Pharmacol. 2008 Feb;153(3):403-5. doi: 10.1038/sj.bjp.0707580. Epub 2007 Nov 26. Br J Pharmacol. 2008. PMID: 18037917 Free PMC article. - Antidiabetic Properties of Curcumin I: Evidence from In Vitro Studies.
Den Hartogh DJ, Gabriel A, Tsiani E. Den Hartogh DJ, et al. Nutrients. 2020 Jan 1;12(1):118. doi: 10.3390/nu12010118. Nutrients. 2020. PMID: 31906278 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical